If this message is not displayed correctly, please click here.
|
|
|
|
|
What´s up at IZB
Dear Mister/Miss Titel ,
there is a fireworks display of exciting news at the IZB right now. In many companies we welcome new managers with excellent industry experience to continue to sustainably implement the visions of the start-ups. In addition, we congratulate Secarna, Thermosome and Bicoll on their research results and funding.
It is a special pleasure to congratulate Prof. Patrick Cramer, former Director of the Gene Center at the Campus, on his new position as President of the Max Planck Society. We are very much looking forward to welcoming him to the site at the next opportunity.
Networking is a top priority at the IZB. This is evident from the many events taking place this summer and next fall. Take the opportunity to exchange ideas with the multipliers at the IZB. At the Munich Life Science Pitch Day (July 13, 2023), 16 project teams will present their research this time. We are happy to welcome more than 40 investors this time - and more are welcome!
Enjoy reading the many news from the IZB.
With best regards
Yours
Dr. Peter Hanns Zobel
Managing Director IZB
|
|
Video IZBrunch June 29, 23
Many thanks to the speakers:
Prof. Dr. Karl Duderstadt, MPI
Research Group "Structure and Dynamics of Molecular Machines". Dynamics of DNA replication, structural biology, single molecule imaging, biophysics.
Jens Klein, Founder & CEO Insempra GmbH.
Topic: How Insempra combines life science and technology to make matter for new, better and more sustainable products on an industrial scale.
|
|
|
Secarna:
New preclinical data show long-term antitumor effects of Secarna Pharmaceuticals’ antisense oligonucleotide (ASO) therapies
The findings from in vivo and in vitro studies were published in the peer-reviewed Journal for ImmunoTherapy of Cancer (JITC).
|
|
|
Spotlight: IZB
Japanese delegation at the IZB
Yosei Ide, State Minister of Education, Culture, Sports, Science and Technology in Tokyo, Japan, besuchte den renommierten Life Science Standort in Martinsried bei München.
|
|
|
ChromoTek:
ChromoTek welcomes Rainer Gebhart as new site manager
In this position, he will manage the research and manufacturing site as well as the commercial aspects of the company.
|
|
|
Networking-Event with Platform Life Sciences
In a relaxed atmosphere, the guests exchanged views on developments in the industry
Dr. Peter Hanns Zobel, Dr. Manuel Bauer, PhD Niels Sharmann, Benedikt Mahr, Dr. Joachim Greuel and Börge Seeger illuminated the biotech scene.
Moderation: Karin Hofelich and Urs Moesenfechtel
|
|
|
Origenis:
Biotech company Origenis welcomes Prof. Hendrik Liebers as Chairman of the Board
The industry expert will play a key role in supporting the company’s strategic development.
|
|
|
Thermosome:
Thermosome joins IMAGIO consortium to advance development of cancer therapies for soft tissue sarcoma
The company will receive EUR 1.3 million in funding and collaborate with Cologne University Hospital to test its lead drug candidate THE001 in combination with a novel technology.
|
|
|
Secarna
Secarna appoints new Chief Business Officer
Dr. Konstantin Petropoulos will be responsible for expanding Secarna’s industry partnering business and securing the financial base for the Company’s aggressive growth plans.
|
|
|
Spotlight: Bicoll
Bicoll showcases at BIO International Convention
The start-up continues to advance projects in neuroscience/epilepsy and dermatology.
|
|
|
Spotlight: KLIFO
Midsommar party at the IZB
On June 15, 2023, the IZB startups celebrated a Scandinavian-Bavarian party and invited the startups and surrounding companies to celebrate. Many thanks to Dr. Anthony Harris and Sophie Markert for this nice action!
|
|
|
BioM:
Bavarian biotechnology maintains its position in the crisis and continues to grow
BioM publishes Bavarian Biotech Report 2022/23
|
|
|
Life Science Pitch Day:
July 13, 2023
Investors welcome!
16 project teams will present their great research to over 40 leading life science investors and decision makers in pharma and VC companies. We look forward to welcoming more investors to participate in this extremely exciting event.
|
|
|
Wirtschaftsempfang:
Postponed to 21 September 2023
Invitation by Kerstin Schreyer, MdL, Chairwoman of the Economic Committee and Dr. Peter Hanns Zobel, Managing Director IZB.
Keynote: Dr. Theo Waigel, former Federal Minister - "Politics in unsteady times".
Start: 7.00 p.m. - End open
|
|
|
MPG:
Official handover ceremony at the Annual Meeting of the Max Planck Society
President Prof. Dr. Martin Stratmann handed over the chain of office to his successor Prof. Dr. Patrick Cramer in front of more than 800 participants..
|
|
|
MPI:
Breakthrough in fluorescence microscopy at the Max Planck Institute of Biochemistry
The research team developed a revolutionary technique that enhances the resolution of fluorescence microscopy down to the Ångström scale..
|
|
|
JOB ADVERTISMENT IZB Start-up
|
|
Job offer:
Scale-Up & Process Development Manager for Recombinant Peptide Protein Production (m/f/d)
|
|
|
Kontakt
Susanne Simon
Leitung Presse- und Öffentlichkeitsarbeit
Tel.: 089/55 279 48-17
E-Mail: izb@izb-online.de
|
Standort Martinsried:
Fördergesellschaft IZB mbH
Am Klopferspitz 19
82152 Planegg/Martinsried
|
Standort Weihenstephan:
Fördergesellschaft IZB mbH
Lise-Meitner-Straße 30
85354 Freising/Weihenstephan
|
|
|
|
|
|
